| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.53 | 0.05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |